Innovating Works

ANGLE

Desconocido
LIMA: Liquid biopsies and Imaging for improved cancer care ANGLE EUROPE LIMITED participó en un H2020: H2020-SC1-2016-2017 LIMA’s overall objective is to develop and validate technologies and tools to include liquid biopsies in the clinical workflow, aiming at in...
2017-11-21 - 2022-06-30 | Financiado
CANCER-ID: Cancer treatment and monitoring through identification of circulating tumour cells and tumour relate... ANGLE EUROPE LIMITED participó en un FP6: Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential...
2015-01-01 - 2019-12-31 | Financiado
CANCER-ID: Cancer treatment and monitoring through identification of circulating tumour cells and tumour relate... ANGLE EUROPE LIMITED participó en un FP7: Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.